Copyright Reports & Markets. All rights reserved.

Global Forzeset Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Forzeset Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 150mg
    • 1.3.3 500mg
  • 1.4 Market Analysis by Combination Therapy
    • 1.4.1 Overview: Global Forzeset Tablets Consumption Value by Combination Therapy: 2021 Versus 2025 Versus 2032
    • 1.4.2 Combined With Immune Checkpoint Inhibitors
    • 1.4.3 Combined With Anti‑Angiogenic Drugs
  • 1.5 Market Analysis by Production Technology
    • 1.5.1 Overview: Global Forzeset Tablets Consumption Value by Production Technology: 2021 Versus 2025 Versus 2032
    • 1.5.2 Original
    • 1.5.3 Generic
  • 1.6 Market Analysis by Sales Channels
    • 1.6.1 Overview: Global Forzeset Tablets Consumption Value by Sales Channels: 2021 Versus 2025 Versus 2032
    • 1.6.2 Hospital
    • 1.6.3 Retail
    • 1.6.4 Online
  • 1.7 Market Analysis by Application
    • 1.7.1 Overview: Global Forzeset Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.7.2 Advanced Non-Small Cell Lung Cancer (NSCLC)
    • 1.7.3 Brain Metastases
    • 1.7.4 Others
  • 1.8 Global Forzeset Tablets Market Size & Forecast
    • 1.8.1 Global Forzeset Tablets Consumption Value (2021 & 2025 & 2032)
    • 1.8.2 Global Forzeset Tablets Sales Quantity (2021-2032)
    • 1.8.3 Global Forzeset Tablets Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 GenFleet Therapeutics
    • 2.1.1 GenFleet Therapeutics Details
    • 2.1.2 GenFleet Therapeutics Major Business
    • 2.1.3 GenFleet Therapeutics Forzeset Tablets Product and Services
    • 2.1.4 GenFleet Therapeutics Forzeset Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 GenFleet Therapeutics Recent Developments/Updates
  • 2.2 Innovent Biologics
    • 2.2.1 Innovent Biologics Details
    • 2.2.2 Innovent Biologics Major Business
    • 2.2.3 Innovent Biologics Forzeset Tablets Product and Services
    • 2.2.4 Innovent Biologics Forzeset Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Innovent Biologics Recent Developments/Updates
  • 2.3 Pharmaron Ningbo manufacturing site
    • 2.3.1 Pharmaron Ningbo manufacturing site Details
    • 2.3.2 Pharmaron Ningbo manufacturing site Major Business
    • 2.3.3 Pharmaron Ningbo manufacturing site Forzeset Tablets Product and Services
    • 2.3.4 Pharmaron Ningbo manufacturing site Forzeset Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Pharmaron Ningbo manufacturing site Recent Developments/Updates

3 Competitive Environment: Forzeset Tablets by Manufacturer

  • 3.1 Global Forzeset Tablets Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Forzeset Tablets Revenue by Manufacturer (2021-2026)
  • 3.3 Global Forzeset Tablets Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Forzeset Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Forzeset Tablets Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Forzeset Tablets Manufacturer Market Share in 2025
  • 3.5 Forzeset Tablets Market: Overall Company Footprint Analysis
    • 3.5.1 Forzeset Tablets Market: Region Footprint
    • 3.5.2 Forzeset Tablets Market: Company Product Type Footprint
    • 3.5.3 Forzeset Tablets Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Forzeset Tablets Market Size by Region
    • 4.1.1 Global Forzeset Tablets Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Forzeset Tablets Consumption Value by Region (2021-2032)
    • 4.1.3 Global Forzeset Tablets Average Price by Region (2021-2032)
  • 4.2 North America Forzeset Tablets Consumption Value (2021-2032)
  • 4.3 Europe Forzeset Tablets Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Forzeset Tablets Consumption Value (2021-2032)
  • 4.5 South America Forzeset Tablets Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Forzeset Tablets Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Forzeset Tablets Sales Quantity by Type (2021-2032)
  • 5.2 Global Forzeset Tablets Consumption Value by Type (2021-2032)
  • 5.3 Global Forzeset Tablets Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Forzeset Tablets Sales Quantity by Application (2021-2032)
  • 6.2 Global Forzeset Tablets Consumption Value by Application (2021-2032)
  • 6.3 Global Forzeset Tablets Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Forzeset Tablets Sales Quantity by Type (2021-2032)
  • 7.2 North America Forzeset Tablets Sales Quantity by Application (2021-2032)
  • 7.3 North America Forzeset Tablets Market Size by Country
    • 7.3.1 North America Forzeset Tablets Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Forzeset Tablets Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Forzeset Tablets Sales Quantity by Type (2021-2032)
  • 8.2 Europe Forzeset Tablets Sales Quantity by Application (2021-2032)
  • 8.3 Europe Forzeset Tablets Market Size by Country
    • 8.3.1 Europe Forzeset Tablets Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Forzeset Tablets Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Forzeset Tablets Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Forzeset Tablets Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Forzeset Tablets Market Size by Region
    • 9.3.1 Asia-Pacific Forzeset Tablets Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Forzeset Tablets Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Forzeset Tablets Sales Quantity by Type (2021-2032)
  • 10.2 South America Forzeset Tablets Sales Quantity by Application (2021-2032)
  • 10.3 South America Forzeset Tablets Market Size by Country
    • 10.3.1 South America Forzeset Tablets Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Forzeset Tablets Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Forzeset Tablets Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Forzeset Tablets Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Forzeset Tablets Market Size by Country
    • 11.3.1 Middle East & Africa Forzeset Tablets Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Forzeset Tablets Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Forzeset Tablets Market Drivers
  • 12.2 Forzeset Tablets Market Restraints
  • 12.3 Forzeset Tablets Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Forzeset Tablets and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Forzeset Tablets
  • 13.3 Forzeset Tablets Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Forzeset Tablets Typical Distributors
  • 14.3 Forzeset Tablets Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Forzeset Tablets market size was valued at US$ 20.58 million in 2025 and is forecast to a readjusted size of US$ 105 million by 2032 with a CAGR of 10.9% during review period.
    Fulzerasib Tablets is an oral, highly selective, irreversible KRAS G12C inhibitor. It is mainly indicated for the treatment of locally advanced or metastatic non‑small cell lung cancer harboring the KRAS G12C mutation. By covalently binding to the cysteine residue of the mutant protein, it locks the KRAS protein in an inactive conformation, blocks the transduction of the downstream MAPK signaling pathway, and thereby inhibits tumor cell proliferation and survival, providing a new domestic targeted therapy option for Chinese patients with advanced lung cancer harboring the KRAS G12C mutation.In 2025, global Fulzerasib Tablets production reached approximately 12,000–15,000 bottles.
    As the first domestically approved KRAS G12C inhibitor in China, Fulzerasib has taken an early lead in entering the market for the treatment of advanced non‑small cell lung cancer, filling the gap in targeted therapy for this target in China. The core driver of its market development lies in medical insurance access and the improvement of the payment system. Its inclusion in medical insurance with a substantial price reduction has significantly lowered the barrier for patients to access the drug and improved its availability and clinical penetration. At present, an intense competitive landscape among similar domestic drugs has taken shape. To maintain its competitiveness, Fulzerasib needs to build differentiated advantages in terms of pricing, indication expansion, and combination therapy regimens based on its clinical efficacy, safety profile, and commercialization network. As the domestic KRAS G12 inhibitor sector enters the volume‑expansion stage following medical insurance inclusion, market competition has shifted from "availability" to "superiority". Future growth will depend on the depth of medical insurance coverage, progress in indication expansion, clinical recognition, and commercial execution capabilities.
    This report is a detailed and comprehensive analysis for global Forzeset Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Forzeset Tablets market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Forzeset Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Forzeset Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Forzeset Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Forzeset Tablets
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Forzeset Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GenFleet Therapeutics, Innovent Biologics, Pharmaron Ningbo manufacturing site, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Forzeset Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    150mg
    500mg
    Market segment by Combination Therapy
    Combined With Immune Checkpoint Inhibitors
    Combined With Anti‑Angiogenic Drugs
    Market segment by Production Technology
    Original
    Generic
    Market segment by Sales Channels
    Hospital
    Retail
    Online
    Market segment by Application
    Advanced Non-Small Cell Lung Cancer (NSCLC)
    Brain Metastases
    Others
    Major players covered
    GenFleet Therapeutics
    Innovent Biologics
    Pharmaron Ningbo manufacturing site
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Forzeset Tablets product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Forzeset Tablets, with price, sales quantity, revenue, and global market share of Forzeset Tablets from 2021 to 2026.
    Chapter 3, the Forzeset Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Forzeset Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Forzeset Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Forzeset Tablets.
    Chapter 14 and 15, to describe Forzeset Tablets sales channel, distributors, customers, research findings and conclusion.

    Buy now